RECURRENT LUNG CANCER
Clinical trials for RECURRENT LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LUNG CANCER trials appear
Sign up with your email to follow new studies for RECURRENT LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets hard-to-treat cancers with KRAS and BRAF mutations
Disease control Recruiting nowThis early-stage study tests an oral drug called S241656 in adults with advanced cancers that have certain gene changes (KRAS, BRAF, or related mutations). The drug is given alone or with other cancer treatments. The goal is to find safe doses and see if the drug shrinks tumors. …
Matched conditions: RECURRENT LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
Tiny seeds zapping lung tumors from the inside – a new hope for recurrent cancer?
Disease control Recruiting nowThis study tests a new way to treat lung cancer that has come back. Doctors place tiny devices called Alpha DaRT seeds directly into the tumor to deliver a special type of radiation. The goal is to see if this is safe and possible for up to 10 adults with small, treatable tumors.…
Matched conditions: RECURRENT LUNG CANCER
Phase: NA • Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated May 26, 2026 08:30 UTC